Nodus Oncology
PrivateLast Round
Seed
Jan 11, 2024
Total Funding Raised
$5.2M
Company Overview
Nodus Oncology is a biotechnology company that develops small molecule therapeutics targeting DNA damage response pathways for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nodus Oncology Comparables
Compare Nodus Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azkarra Therapeutics | 86% | |
| FoRx Therapeutics | 86% | |
| Artios Pharma | 82% |
Nodus Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 11, 2024 | ||||
| Seed | Feb 7, 2023 | ||||
| Seed | Sep 6, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 57% MoM.
- Jan 19, 2026
Monthly visitors increased 44% MoM.
Nodus Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nodus Oncology's valuation, stock price, and market status.
Is Nodus Oncology a public or private company?
Nodus Oncology is a private company.
What is the current stock price of Nodus Oncology?
Nodus Oncology is a private company, so its shares have no public market price. Caplight tracks Nodus Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nodus Oncology worth (valuation)?
Valuation information for Nodus Oncology is not publicly available.
Can I buy Nodus Oncology stock?
Nodus Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nodus Oncology's last funding round?
Nodus Oncology's most recent funding round was Seed on January 11, 2024.
Who are the main investors in Nodus Oncology?
Investor information for Nodus Oncology is not publicly disclosed.
Will Nodus Oncology IPO soon?
No public IPO plans have been announced for Nodus Oncology.
How can I track Nodus Oncology secondary market activity?
Caplight tracks bids, offers, and trades in Nodus Oncology's shares on secondary markets.